Skip to main content

Together we are beating cancer

Donate now

Cancer News

Clinical trials

Showing 12 out of 313 results
Cancer Research UK logo

Three times as many women with advanced lung cancer were alive and had no progression of their cancer 12 months after taking the drug erlotinib (also known as Tarceva) compared to those who did not receive the drug according to new data being presented at the ASCO conference today (Monday). Three times as many women with advanced lung cancer were alive and had no progression of their cancer 12 months after taking the drug erlotinib (also known as Tarceva) compared to those who did not receive the drug according to new data being presented at the ASCO conference today (Monday).

by Cancer Research UK | News | 7 June 2010

7 June 2010

Cancer Research UK logo

Cancer Research UK this week launches a new trial for patients with bowel cancer that has spread to the liver to see whether a new radiotherapy treatment technique is more effective than standard chemotherapy. Cancer Research UK this week launches a new trial for patients with bowel cancer that has spread to the liver to see whether a new radiotherapy treatment technique is more effective than standard chemotherapy.

by Cancer Research UK | News | 25 February 2010

25 February 2010